Prince Pharmaceutical Co Ltd
TPEX:6935
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Prince Pharmaceutical Co Ltd.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Prince Pharmaceutical Does
Prince Pharmaceutical Co. Ltd. principally engages in the production of active pharmaceutical ingredients of Vitamin B1. The company is headquartered in Huwei, Yunlin and currently employs 216 full-time employees. The company went IPO on 2023-03-29. The firm's main business is divided into ingredients business and health food business. The ingredients business currently consists of phlegm dispelling agents, vitamin B1 derivatives, and non-steroidal anti-inflammatory drugs.
- Headquarters
- Taiwan TW
- Employees
- 216
- IPO date
- Mar 29, 2023
Balance Sheet
Continue Research
Decided on Prince Pharmaceutical? Get an email when Prince Pharmaceutical Co Ltd reaches the price you’d buy at. Free with an account.